Between January 2009 and April 2016, 134 novel anticancer therapies were approved: what is the level of knowledge concerning the clinical benefit at the time of approval?

Grössmann, Nicole; Wild, Claudia

Grössmann, Nicole; Wild, Claudia.

Afiliación

Grössmann N; Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, Austria.
Wild C; Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, Austria.

ESMO Open ; 1(6): e000125, 2016.

Article en En | MEDLINE | ID: mdl-28848662

Palabras clave

clinical benefit; health technology assessment; marketing authorisation; novel therapies

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_technology_assessment / Prognostic_studies Idioma: En Revista: ESMO Open Año: 2016 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google